Related references
Note: Only part of the references are listed.microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1
Hui Wang et al.
BMC CANCER (2019)
MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression
Yue Zhu et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1
Chongyu Su et al.
CANCER MEDICINE (2018)
miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2
Qiuyan Zhao et al.
CELL DEATH & DISEASE (2018)
CCR7 Mediates TGF-1-Induced Human Malignant Glioma Invasion, Migration, and Epithelial-Mesenchymal Transition by Activating MMP2/9 Through the Nuclear Factor KappaB Signaling Pathway
Yanyan Zheng et al.
DNA AND CELL BIOLOGY (2017)
MiR-129-5p Inhibits Proliferation and Invasion of Chondrosarcoma Cells by Regulating SOX4/Wnt/β-Catenin Signaling Pathway
Peng Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways
Mingli Han et al.
ONCOLOGY REPORTS (2016)
miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A
Yandong Lu et al.
ONCOLOGY RESEARCH (2016)
Significance of microRNA 21 in gastric cancer
Durairaj Sekar et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
miRNA-21 as a novel therapeutic target in lung cancer
Athina Markou et al.
LUNG CANCER-TARGETS AND THERAPY (2016)
The Regulatory Role of MicroRNAs in EMT and Cancer
Apostolos Zaravinos
JOURNAL OF ONCOLOGY (2015)
MicroRNA-21 as a potential colon and rectal cancer biomarker
Tao Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
Masahiro Seike et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The clinical approach towards chondrosarcoma
Hans Gelderblom et al.
ONCOLOGIST (2008)